How is this not price sensitive??
This poster provides further evidence confirming, in a mouse model of triple negative breast cancer
(TNBC) brain metastases, that PAT-DX1 is able to cross the blood-brain barrier and reduce TNBC brain
metastasis after a single week of treatment. Furthermore, mice treated for 4 weeks with PAT-DX1
showed 93% less brain metastasis than untreated mice. Animals treated with PAT-DX1 for 4 weeks
survived 45% longer than untreated animals and no toxicity was associated with PAT-DX1 treatment
WOW..... $36m market cap....this wont be here for long
Changing sentiment to BUY.
Ann: Poster Presentation at San Antonio Breast Cancer Symposium, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
